Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 30, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Power and sample size for cost-effectiveness analysis: fFN neonatal screening.

Kathleen A Boyd1, Andrew H Briggs, Elisabeth Fenwick

  • 1University of Glasgow, Glasgow, UK. Kathleen.Boyd@glasgow.ac.uk

Contemporary Clinical Trials
|July 26, 2011
PubMed
Summary

Calculating sample sizes for cost-effectiveness in clinical trials is feasible using the net monetary benefit approach. This method ensures trials are powered for economic outcomes, not just effectiveness, guiding trial design and non-inferiority margins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluation.

Health technology assessment (Winchester, England)·2026
Same author

From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.

Journal of medical economics·2026
Same author

Cardiovascular-Kidney-Metabolic Syndrome: Conceptualising an Approach to Health Economic Modelling.

Diabetes, obesity & metabolism·2026
Same author

PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data.

Health technology assessment (Winchester, England)·2026
Same author

Cost-effectiveness of a mTB-Tobacco intervention for smoking cessation in people with tuberculosis: an economic evaluation of a cluster randomised controlled trial.

The Lancet regional health. Southeast Asia·2026
Same author

Duration of external neck stabilisation in the management of older and frail patients with a new odontoid fracture: the DENS RCT.

Health technology assessment (Winchester, England)·2026

Area of Science:

  • Health economics
  • Clinical trial design
  • Biostatistics

Background:

  • Randomised controlled trials (RCTs) with cost-effectiveness evaluations often neglect health economic input for sample size calculations.
  • Sample size calculations should align with cost-effectiveness outcomes when it's the primary endpoint.

Purpose of the Study:

  • Demonstrate the feasibility of sample size calculation for cost-effectiveness in a real-world setting using the net monetary benefit (NMB) approach.
  • Propose a framework for integrating economic considerations into clinical trial design.

Main Methods:

  • Utilized the net monetary benefit (NMB) approach for cost-effectiveness analysis.
  • Calculated sample sizes for a proposed RCT of fetal fibronectin screening (fFN) for threatened pre-term labour.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Related Experiment Videos

Last Updated: May 30, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

  • Performed probabilistic analysis to explore parameter uncertainty and its impact on sample size.
  • Main Results:

    • The NMB approach was used to calculate required sample sizes for various statistical powers.
    • Sample size calculations were adjusted using a non-inferiority margin to ensure effectiveness endpoint sufficiency.
    • Pre-trial predictions indicated potential cost-savings with a minor negative impact on neonatal morbidity.

    Conclusions:

    • Economic assessments should guide conventional clinical trial design.
    • The NMB approach is feasible for determining sample sizes in cost-effectiveness studies.
    • Economic considerations can effectively guide the establishment of non-inferiority margins.